Titre:
  • Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.
Auteur:Mattarollo, Stephen R; Loi, Sherene; Duret, Helene; Ma, Yuting; Zitvogel, Laurence; Smyth, Mark J
Informations sur la publication:Cancer research, 71, 14, page (4809-4820)
Statut de publication:Publié, 2011-07
Sujet CREF:Cancérologie
MeSH keywords:Adaptive Immunity -- drug effects -- immunology
Adenocarcinoma -- drug therapy -- genetics -- immunology
Animals
Antibiotics, Antineoplastic -- immunology -- pharmacology
Antigens, CD8 -- biosynthesis -- genetics -- immunology
CD8-Positive T-Lymphocytes -- immunology
Doxorubicin -- immunology -- pharmacology
Epitopes, T-Lymphocyte -- immunology
Female
Fibrosarcoma -- drug therapy -- genetics -- immunology
Gene Expression
Immunity, Innate -- drug effects -- immunology
Interferon-gamma -- biosynthesis -- genetics -- immunology
Interleukin-17 -- immunology
Lymphocytes, Tumor-Infiltrating -- immunology
Male
Mammary Neoplasms, Experimental -- drug therapy -- genetics -- immunology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Transgenic
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0008-5472
info:doi/10.1158/0008-5472.CAN-11-0753
info:pii/0008-5472.CAN-11-0753
info:scp/79960426821
info:pmid/21646474